Pharmacoeconomics: Open Access

Consumption and Expenditure of Direct Oral Anticoagulants during the COVID-19 Pandemic in Russia and Associated Clinical Practice Guidelines

Abstract

Siddle Fabiana*

The COVID-19 pandemic has profoundly affected global healthcare systems, reshaping treatment protocols and altering the dynamics of pharmaceutical consumption and expenditure. Among the therapeutic areas impacted, the use of anticoagulants has seen significant shifts due to the pandemic's thromboembolic complications and their management. In Russia, the consumption and expenditure of direct oral anticoagulants provide a compelling case study of how clinical needs and policy decisions intersect during a global health crisis.